Sponsors (2)
The bill sharply reduces asbestos-related health and environmental risks by banning most uses while easing short-term disruptions with narrow, time‑limited exemptions — a trade-off that improves public health but creates transition costs, potential price impacts, enforcement complexity, and limited continued exposure risks where exemptions apply.
Construction workers, energy workers, hospital staff, and building occupants will face substantially reduced exposure because the bill bans manufacture, processing, use, and distribution of commercial asbestos on enactment.
Communities near former asbestos‑using facilities — often low‑income areas — should experience lower long‑term environmental contamination and related health risks from cessation of asbestos use nationwide.
Homeowners, renters, and building owners can lawfully retain existing in‑place asbestos materials, avoiding immediate, widespread costly removals and associated disruption.
Workers at facilities still authorized to use asbestos (notably in the chlor‑alkali sector) will face continued exposure risks until the authorization ends or is extended.
Taxpayers and consumers could see higher prices if chlor‑alkali producers pass transition or replacement costs on to downstream industries and customers.
A presidential national‑security exemption process permits one‑time waivers that could allow continued asbestos use in some cases, undermining the ban and risking ongoing exposures.
Based on analysis of 2 sections of legislative text.
Bans manufacture, processing, use, and distribution of eight named commercial asbestos minerals and related articles under TSCA, with a limited chlor‑alkali exemption through 2032 (possible extension to 2036).
Official title: Amend the Toxic Substances Control Act to prohibit the manufacture, processing, use, and distribution in commerce of commercial asbestos and mixtures and articles containing commercial asbestos, and for other purposes.
Introduced August 4, 2026 by Jeff Merkley · Last progress August 4, 2026
Bans the manufacture, processing, use, and distribution in commerce of eight named commercial asbestos minerals and mixtures/articles that contain them, while carving out narrow exclusions for existing in‑place asbestos and for disposal. The law adds a new statutory prohibition under the Toxic Substances Control Act and defines terms and limited exceptions, including a time‑limited allowance for certain chlor‑alkali facilities to continue using chrysotile asbestos diaphragms through 2032 (with a possible extension to 2036 for a narrowly defined subgroup) under interim exposure‑control rules. The measure clarifies that the new TSCA prohibitions apply only to chemical substances regulated under TSCA and do not alter other asbestos rules (for example workplace safety or building/materials law). It also excludes distribution solely for lawful disposal and treats trace impurities differently from intentionally added commercial asbestos.